BNP Paribas Financial Markets’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.1M Buy
1,456,857
+1,331,230
+1,060% +$11.9M 0.01% 959
2025
Q1
$942K Sell
125,627
-70,598
-36% -$529K ﹤0.01% 2072
2024
Q4
$1.48M Sell
196,225
-300,559
-61% -$2.26M ﹤0.01% 1855
2024
Q3
$3.78M Buy
496,784
+409,938
+472% +$3.12M ﹤0.01% 1126
2024
Q2
$537K Sell
86,846
-80,936
-48% -$500K ﹤0.01% 1988
2024
Q1
$852K Sell
167,782
-622,381
-79% -$3.16M ﹤0.01% 1970
2023
Q4
$4.73M Buy
790,163
+247,195
+46% +$1.48M 0.01% 996
2023
Q3
$3.84M Buy
542,968
+327,226
+152% +$2.32M ﹤0.01% 1039
2023
Q2
$1.52M Sell
215,742
-124,649
-37% -$878K ﹤0.01% 1418
2023
Q1
$2.84M Buy
340,391
+183,818
+117% +$1.53M ﹤0.01% 1171
2022
Q4
$1.8M Sell
156,573
-83,307
-35% -$956K ﹤0.01% 1300
2022
Q3
$3.02M Buy
239,880
+199,198
+490% +$2.51M ﹤0.01% 1183
2022
Q2
$430K Buy
40,682
+14,837
+57% +$157K ﹤0.01% 2133
2022
Q1
$420K Sell
25,845
-40,011
-61% -$651K ﹤0.01% 2291
2021
Q4
$912K Buy
65,856
+21,952
+50% +$304K ﹤0.01% 2078
2021
Q3
$631K Buy
43,904
+27,151
+162% +$390K ﹤0.01% 2089
2021
Q2
$265K Sell
16,753
-13,795
-45% -$218K ﹤0.01% 2210
2021
Q1
$311K Buy
30,548
+11,781
+63% +$120K ﹤0.01% 2294
2020
Q4
$140K Sell
18,767
-22,437
-54% -$167K ﹤0.01% 2412
2020
Q3
$142K Buy
41,204
+5,467
+15% +$18.8K ﹤0.01% 2322
2020
Q2
$170K Sell
35,737
-34,780
-49% -$166K ﹤0.01% 1953
2020
Q1
$141K Buy
70,517
+53,338
+310% +$107K ﹤0.01% 2448
2019
Q4
$59.3K Sell
17,179
-279
-2% -$963 ﹤0.01% 2888
2019
Q3
$50K Buy
17,458
+5,197
+42% +$14.9K ﹤0.01% 2845
2019
Q2
$46.5K Sell
12,261
-10,450
-46% -$39.6K ﹤0.01% 2847
2019
Q1
$185K Buy
22,711
+22,674
+61,281% +$185K ﹤0.01% 2183
2018
Q4
$299 Sell
37
-3,220
-99% -$26K ﹤0.01% 3371
2018
Q3
$24.9K Hold
3,257
﹤0.01% 2666
2018
Q2
$18.7K Sell
3,257
-17,056
-84% -$97.7K ﹤0.01% 2877
2018
Q1
$96.9K Sell
20,313
-143
-0.7% -$682 ﹤0.01% 2624
2017
Q4
$100K Buy
20,456
+12,186
+147% +$59.8K ﹤0.01% 2651
2017
Q3
$43.3K Sell
8,270
-584
-7% -$3.06K ﹤0.01% 2748
2017
Q2
$49.2K Buy
8,854
+8,486
+2,306% +$47.2K ﹤0.01% 2724
2017
Q1
$3.09K Sell
368
-3,744
-91% -$31.4K ﹤0.01% 2864
2016
Q4
$26K Sell
4,112
-994
-19% -$6.29K ﹤0.01% 2592
2016
Q3
$22.5K Buy
5,106
+2,194
+75% +$9.68K ﹤0.01% 2826
2016
Q2
$8.27K Buy
+2,912
New +$8.27K ﹤0.01% 3003
2016
Q1
Sell
-14,796
Closed -$153K 2699
2015
Q4
$153K Sell
14,796
-198
-1% -$2.04K ﹤0.01% 2098
2015
Q3
$171K Buy
14,994
+8,961
+149% +$102K ﹤0.01% 2064
2015
Q2
$90.1K Buy
6,033
+4,383
+266% +$65.4K ﹤0.01% 2136
2015
Q1
$14.9K Buy
+1,650
New +$14.9K ﹤0.01% 2525
2014
Q4
Sell
-4,191
Closed -$41K 2058
2014
Q3
$41K Buy
+4,191
New +$41K ﹤0.01% 2271